Your browser doesn't support javascript.
loading
PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression.
Filippone, A; Lanza, M; Mannino, D; Raciti, G; Colarossi, C; Sciacca, D; Cuzzocrea, S; Paterniti, I.
Affiliation
  • Filippone A; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, viale Ferdinando Stagno D'Alcontres, 31, 98166, Messina, Italy.
  • Lanza M; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, viale Ferdinando Stagno D'Alcontres, 31, 98166, Messina, Italy.
  • Mannino D; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, viale Ferdinando Stagno D'Alcontres, 31, 98166, Messina, Italy.
  • Raciti G; IOM Ricerca Srl, via Penninazzo 11, 95029, Catania, Italy.
  • Colarossi C; Instituto Oncologico del Mediterraneo, via Penninazzo 7, 95029, Catania, Italy.
  • Sciacca D; Instituto Oncologico del Mediterraneo, via Penninazzo 7, 95029, Catania, Italy.
  • Cuzzocrea S; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, viale Ferdinando Stagno D'Alcontres, 31, 98166, Messina, Italy.
  • Paterniti I; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, viale Ferdinando Stagno D'Alcontres, 31, 98166, Messina, Italy. ipaterniti@unime.it.
Cancer Immunol Immunother ; 71(9): 2067-2075, 2022 Sep.
Article in En | MEDLINE | ID: mdl-35092481

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / B7-H1 Antigen / Programmed Cell Death 1 Receptor / Immune Checkpoint Proteins Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2022 Type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / B7-H1 Antigen / Programmed Cell Death 1 Receptor / Immune Checkpoint Proteins Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2022 Type: Article Affiliation country: Italy